Medical Care
Global CAR-T Drugs Market Research Report 2025
- Nov 18, 25
- ID: 289389
- Pages: 76
- Figures: 77
- Views: 58
This report aims to provide a comprehensive presentation of the global market for CAR-T Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Drugs.
The CAR-T Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, by Source and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Novartis
Bristol Myers Squibb
Johnson & Johnson (Legend Biotech)
Fosun Kairos
ISAO Bio
JW (Cayman) Therapeutics
CARsgen Therapeutics
Juventas Cell Therapy
Hrain Biotechnology Co
Segment by Type
Single Target
Multiple Targets
Segment by Source
Autologous
Allogeneic
Segment by Generation
First Generation
Second Generation
Third Generation
Fourth Generation
Segment by Application
Hematoma
Solid Tumors
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Source etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The CAR-T Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, by Source and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Novartis
Bristol Myers Squibb
Johnson & Johnson (Legend Biotech)
Fosun Kairos
ISAO Bio
JW (Cayman) Therapeutics
CARsgen Therapeutics
Juventas Cell Therapy
Hrain Biotechnology Co
Segment by Type
Single Target
Multiple Targets
Segment by Source
Autologous
Allogeneic
Segment by Generation
First Generation
Second Generation
Third Generation
Fourth Generation
Segment by Application
Hematoma
Solid Tumors
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Source etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single Target
1.2.3 Multiple Targets
1.3 Market by Source
1.3.1 Global CAR-T Drugs Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.3.2 Autologous
1.3.3 Allogeneic
1.4 Market by Generation
1.4.1 Global CAR-T Drugs Market Size Growth Rate by Generation: 2020 VS 2024 VS 2031
1.4.2 First Generation
1.4.3 Second Generation
1.4.4 Third Generation
1.4.5 Fourth Generation
1.5 Market by Application
1.5.1 Global CAR-T Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hematoma
1.5.3 Solid Tumors
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Drugs Market Perspective (2020-2031)
2.2 Global CAR-T Drugs Growth Trends by Region
2.2.1 Global CAR-T Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CAR-T Drugs Historic Market Size by Region (2020-2025)
2.2.3 CAR-T Drugs Forecasted Market Size by Region (2026-2031)
2.3 CAR-T Drugs Market Dynamics
2.3.1 CAR-T Drugs Industry Trends
2.3.2 CAR-T Drugs Market Drivers
2.3.3 CAR-T Drugs Market Challenges
2.3.4 CAR-T Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Drugs Players by Revenue
3.1.1 Global Top CAR-T Drugs Players by Revenue (2020-2025)
3.1.2 Global CAR-T Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Top CAR-T Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CAR-T Drugs Revenue
3.4 Global CAR-T Drugs Market Concentration Ratio
3.4.1 Global CAR-T Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Drugs Revenue in 2024
3.5 Global Key Players of CAR-T Drugs Head office and Area Served
3.6 Global Key Players of CAR-T Drugs, Product and Application
3.7 Global Key Players of CAR-T Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Drugs Breakdown Data by Type
4.1 Global CAR-T Drugs Historic Market Size by Type (2020-2025)
4.2 Global CAR-T Drugs Forecasted Market Size by Type (2026-2031)
5 CAR-T Drugs Breakdown Data by Application
5.1 Global CAR-T Drugs Historic Market Size by Application (2020-2025)
5.2 Global CAR-T Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CAR-T Drugs Market Size (2020-2031)
6.2 North America CAR-T Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CAR-T Drugs Market Size by Country (2020-2025)
6.4 North America CAR-T Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Drugs Market Size (2020-2031)
7.2 Europe CAR-T Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CAR-T Drugs Market Size by Country (2020-2025)
7.4 Europe CAR-T Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Drugs Market Size (2020-2031)
8.2 Asia-Pacific CAR-T Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CAR-T Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific CAR-T Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CAR-T Drugs Market Size (2020-2031)
9.2 Latin America CAR-T Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CAR-T Drugs Market Size by Country (2020-2025)
9.4 Latin America CAR-T Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Drugs Market Size (2020-2031)
10.2 Middle East & Africa CAR-T Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CAR-T Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa CAR-T Drugs Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences CAR-T Drugs Introduction
11.1.4 Gilead Sciences Revenue in CAR-T Drugs Business (2020-2025)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis CAR-T Drugs Introduction
11.2.4 Novartis Revenue in CAR-T Drugs Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb CAR-T Drugs Introduction
11.3.4 Bristol Myers Squibb Revenue in CAR-T Drugs Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Johnson & Johnson (Legend Biotech)
11.4.1 Johnson & Johnson (Legend Biotech) Company Details
11.4.2 Johnson & Johnson (Legend Biotech) Business Overview
11.4.3 Johnson & Johnson (Legend Biotech) CAR-T Drugs Introduction
11.4.4 Johnson & Johnson (Legend Biotech) Revenue in CAR-T Drugs Business (2020-2025)
11.4.5 Johnson & Johnson (Legend Biotech) Recent Development
11.5 Fosun Kairos
11.5.1 Fosun Kairos Company Details
11.5.2 Fosun Kairos Business Overview
11.5.3 Fosun Kairos CAR-T Drugs Introduction
11.5.4 Fosun Kairos Revenue in CAR-T Drugs Business (2020-2025)
11.5.5 Fosun Kairos Recent Development
11.6 ISAO Bio
11.6.1 ISAO Bio Company Details
11.6.2 ISAO Bio Business Overview
11.6.3 ISAO Bio CAR-T Drugs Introduction
11.6.4 ISAO Bio Revenue in CAR-T Drugs Business (2020-2025)
11.6.5 ISAO Bio Recent Development
11.7 JW (Cayman) Therapeutics
11.7.1 JW (Cayman) Therapeutics Company Details
11.7.2 JW (Cayman) Therapeutics Business Overview
11.7.3 JW (Cayman) Therapeutics CAR-T Drugs Introduction
11.7.4 JW (Cayman) Therapeutics Revenue in CAR-T Drugs Business (2020-2025)
11.7.5 JW (Cayman) Therapeutics Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Details
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics CAR-T Drugs Introduction
11.8.4 CARsgen Therapeutics Revenue in CAR-T Drugs Business (2020-2025)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Juventas Cell Therapy
11.9.1 Juventas Cell Therapy Company Details
11.9.2 Juventas Cell Therapy Business Overview
11.9.3 Juventas Cell Therapy CAR-T Drugs Introduction
11.9.4 Juventas Cell Therapy Revenue in CAR-T Drugs Business (2020-2025)
11.9.5 Juventas Cell Therapy Recent Development
11.10 Hrain Biotechnology Co
11.10.1 Hrain Biotechnology Co Company Details
11.10.2 Hrain Biotechnology Co Business Overview
11.10.3 Hrain Biotechnology Co CAR-T Drugs Introduction
11.10.4 Hrain Biotechnology Co Revenue in CAR-T Drugs Business (2020-2025)
11.10.5 Hrain Biotechnology Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single Target
1.2.3 Multiple Targets
1.3 Market by Source
1.3.1 Global CAR-T Drugs Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.3.2 Autologous
1.3.3 Allogeneic
1.4 Market by Generation
1.4.1 Global CAR-T Drugs Market Size Growth Rate by Generation: 2020 VS 2024 VS 2031
1.4.2 First Generation
1.4.3 Second Generation
1.4.4 Third Generation
1.4.5 Fourth Generation
1.5 Market by Application
1.5.1 Global CAR-T Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hematoma
1.5.3 Solid Tumors
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Drugs Market Perspective (2020-2031)
2.2 Global CAR-T Drugs Growth Trends by Region
2.2.1 Global CAR-T Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CAR-T Drugs Historic Market Size by Region (2020-2025)
2.2.3 CAR-T Drugs Forecasted Market Size by Region (2026-2031)
2.3 CAR-T Drugs Market Dynamics
2.3.1 CAR-T Drugs Industry Trends
2.3.2 CAR-T Drugs Market Drivers
2.3.3 CAR-T Drugs Market Challenges
2.3.4 CAR-T Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Drugs Players by Revenue
3.1.1 Global Top CAR-T Drugs Players by Revenue (2020-2025)
3.1.2 Global CAR-T Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Top CAR-T Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CAR-T Drugs Revenue
3.4 Global CAR-T Drugs Market Concentration Ratio
3.4.1 Global CAR-T Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Drugs Revenue in 2024
3.5 Global Key Players of CAR-T Drugs Head office and Area Served
3.6 Global Key Players of CAR-T Drugs, Product and Application
3.7 Global Key Players of CAR-T Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Drugs Breakdown Data by Type
4.1 Global CAR-T Drugs Historic Market Size by Type (2020-2025)
4.2 Global CAR-T Drugs Forecasted Market Size by Type (2026-2031)
5 CAR-T Drugs Breakdown Data by Application
5.1 Global CAR-T Drugs Historic Market Size by Application (2020-2025)
5.2 Global CAR-T Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CAR-T Drugs Market Size (2020-2031)
6.2 North America CAR-T Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CAR-T Drugs Market Size by Country (2020-2025)
6.4 North America CAR-T Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Drugs Market Size (2020-2031)
7.2 Europe CAR-T Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CAR-T Drugs Market Size by Country (2020-2025)
7.4 Europe CAR-T Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Drugs Market Size (2020-2031)
8.2 Asia-Pacific CAR-T Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CAR-T Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific CAR-T Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America CAR-T Drugs Market Size (2020-2031)
9.2 Latin America CAR-T Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CAR-T Drugs Market Size by Country (2020-2025)
9.4 Latin America CAR-T Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Drugs Market Size (2020-2031)
10.2 Middle East & Africa CAR-T Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CAR-T Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa CAR-T Drugs Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences CAR-T Drugs Introduction
11.1.4 Gilead Sciences Revenue in CAR-T Drugs Business (2020-2025)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis CAR-T Drugs Introduction
11.2.4 Novartis Revenue in CAR-T Drugs Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb CAR-T Drugs Introduction
11.3.4 Bristol Myers Squibb Revenue in CAR-T Drugs Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Johnson & Johnson (Legend Biotech)
11.4.1 Johnson & Johnson (Legend Biotech) Company Details
11.4.2 Johnson & Johnson (Legend Biotech) Business Overview
11.4.3 Johnson & Johnson (Legend Biotech) CAR-T Drugs Introduction
11.4.4 Johnson & Johnson (Legend Biotech) Revenue in CAR-T Drugs Business (2020-2025)
11.4.5 Johnson & Johnson (Legend Biotech) Recent Development
11.5 Fosun Kairos
11.5.1 Fosun Kairos Company Details
11.5.2 Fosun Kairos Business Overview
11.5.3 Fosun Kairos CAR-T Drugs Introduction
11.5.4 Fosun Kairos Revenue in CAR-T Drugs Business (2020-2025)
11.5.5 Fosun Kairos Recent Development
11.6 ISAO Bio
11.6.1 ISAO Bio Company Details
11.6.2 ISAO Bio Business Overview
11.6.3 ISAO Bio CAR-T Drugs Introduction
11.6.4 ISAO Bio Revenue in CAR-T Drugs Business (2020-2025)
11.6.5 ISAO Bio Recent Development
11.7 JW (Cayman) Therapeutics
11.7.1 JW (Cayman) Therapeutics Company Details
11.7.2 JW (Cayman) Therapeutics Business Overview
11.7.3 JW (Cayman) Therapeutics CAR-T Drugs Introduction
11.7.4 JW (Cayman) Therapeutics Revenue in CAR-T Drugs Business (2020-2025)
11.7.5 JW (Cayman) Therapeutics Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Details
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics CAR-T Drugs Introduction
11.8.4 CARsgen Therapeutics Revenue in CAR-T Drugs Business (2020-2025)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Juventas Cell Therapy
11.9.1 Juventas Cell Therapy Company Details
11.9.2 Juventas Cell Therapy Business Overview
11.9.3 Juventas Cell Therapy CAR-T Drugs Introduction
11.9.4 Juventas Cell Therapy Revenue in CAR-T Drugs Business (2020-2025)
11.9.5 Juventas Cell Therapy Recent Development
11.10 Hrain Biotechnology Co
11.10.1 Hrain Biotechnology Co Company Details
11.10.2 Hrain Biotechnology Co Business Overview
11.10.3 Hrain Biotechnology Co CAR-T Drugs Introduction
11.10.4 Hrain Biotechnology Co Revenue in CAR-T Drugs Business (2020-2025)
11.10.5 Hrain Biotechnology Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CAR-T Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Single Target
Table 3. Key Players of Multiple Targets
Table 4. Global CAR-T Drugs Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Autologous
Table 6. Key Players of Allogeneic
Table 7. Global CAR-T Drugs Market Size Growth Rate by Generation (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of First Generation
Table 9. Key Players of Second Generation
Table 10. Key Players of Third Generation
Table 11. Key Players of Fourth Generation
Table 12. Global CAR-T Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 13. Global CAR-T Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global CAR-T Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 15. Global CAR-T Drugs Market Share by Region (2020-2025)
Table 16. Global CAR-T Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 17. Global CAR-T Drugs Market Share by Region (2026-2031)
Table 18. CAR-T Drugs Market Trends
Table 19. CAR-T Drugs Market Drivers
Table 20. CAR-T Drugs Market Challenges
Table 21. CAR-T Drugs Market Restraints
Table 22. Global CAR-T Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 23. Global CAR-T Drugs Market Share by Players (2020-2025)
Table 24. Global Top CAR-T Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Drugs as of 2024)
Table 25. Ranking of Global Top CAR-T Drugs Companies by Revenue (US$ Million) in 2024
Table 26. Global 5 Largest Players Market Share by CAR-T Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 27. Global Key Players of CAR-T Drugs, Headquarters and Area Served
Table 28. Global Key Players of CAR-T Drugs, Product and Application
Table 29. Global Key Players of CAR-T Drugs, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CAR-T Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 32. Global CAR-T Drugs Revenue Market Share by Type (2020-2025)
Table 33. Global CAR-T Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 34. Global CAR-T Drugs Revenue Market Share by Type (2026-2031)
Table 35. Global CAR-T Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 36. Global CAR-T Drugs Revenue Market Share by Application (2020-2025)
Table 37. Global CAR-T Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 38. Global CAR-T Drugs Revenue Market Share by Application (2026-2031)
Table 39. North America CAR-T Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. North America CAR-T Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 41. North America CAR-T Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 42. Europe CAR-T Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Europe CAR-T Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Europe CAR-T Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Asia-Pacific CAR-T Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 46. Asia-Pacific CAR-T Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 47. Asia-Pacific CAR-T Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 48. Latin America CAR-T Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Latin America CAR-T Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 50. Latin America CAR-T Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 51. Middle East & Africa CAR-T Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Middle East & Africa CAR-T Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 53. Middle East & Africa CAR-T Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 54. Gilead Sciences Company Details
Table 55. Gilead Sciences Business Overview
Table 56. Gilead Sciences CAR-T Drugs Product
Table 57. Gilead Sciences Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 58. Gilead Sciences Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis CAR-T Drugs Product
Table 62. Novartis Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Bristol Myers Squibb Company Details
Table 65. Bristol Myers Squibb Business Overview
Table 66. Bristol Myers Squibb CAR-T Drugs Product
Table 67. Bristol Myers Squibb Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 68. Bristol Myers Squibb Recent Development
Table 69. Johnson & Johnson (Legend Biotech) Company Details
Table 70. Johnson & Johnson (Legend Biotech) Business Overview
Table 71. Johnson & Johnson (Legend Biotech) CAR-T Drugs Product
Table 72. Johnson & Johnson (Legend Biotech) Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 73. Johnson & Johnson (Legend Biotech) Recent Development
Table 74. Fosun Kairos Company Details
Table 75. Fosun Kairos Business Overview
Table 76. Fosun Kairos CAR-T Drugs Product
Table 77. Fosun Kairos Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 78. Fosun Kairos Recent Development
Table 79. ISAO Bio Company Details
Table 80. ISAO Bio Business Overview
Table 81. ISAO Bio CAR-T Drugs Product
Table 82. ISAO Bio Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 83. ISAO Bio Recent Development
Table 84. JW (Cayman) Therapeutics Company Details
Table 85. JW (Cayman) Therapeutics Business Overview
Table 86. JW (Cayman) Therapeutics CAR-T Drugs Product
Table 87. JW (Cayman) Therapeutics Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 88. JW (Cayman) Therapeutics Recent Development
Table 89. CARsgen Therapeutics Company Details
Table 90. CARsgen Therapeutics Business Overview
Table 91. CARsgen Therapeutics CAR-T Drugs Product
Table 92. CARsgen Therapeutics Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 93. CARsgen Therapeutics Recent Development
Table 94. Juventas Cell Therapy Company Details
Table 95. Juventas Cell Therapy Business Overview
Table 96. Juventas Cell Therapy CAR-T Drugs Product
Table 97. Juventas Cell Therapy Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 98. Juventas Cell Therapy Recent Development
Table 99. Hrain Biotechnology Co Company Details
Table 100. Hrain Biotechnology Co Business Overview
Table 101. Hrain Biotechnology Co CAR-T Drugs Product
Table 102. Hrain Biotechnology Co Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 103. Hrain Biotechnology Co Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. CAR-T Drugs Picture
Figure 2. Global CAR-T Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-T Drugs Market Share by Type: 2024 VS 2031
Figure 4. Single Target Features
Figure 5. Multiple Targets Features
Figure 6. Global CAR-T Drugs Market Size Comparison by Source (2020-2031) & (US$ Million)
Figure 7. Autologous Features
Figure 8. Allogeneic Features
Figure 9. Global CAR-T Drugs Market Size Comparison by Generation (2020-2031) & (US$ Million)
Figure 10. First Generation Features
Figure 11. Second Generation Features
Figure 12. Third Generation Features
Figure 13. Fourth Generation Features
Figure 14. Global CAR-T Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 15. Global CAR-T Drugs Market Share by Application: 2024 VS 2031
Figure 16. Hematoma Case Studies
Figure 17. Solid Tumors Case Studies
Figure 18. Others Case Studies
Figure 19. CAR-T Drugs Report Years Considered
Figure 20. Global CAR-T Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 21. Global CAR-T Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 22. Global CAR-T Drugs Market Share by Region: 2024 VS 2031
Figure 23. Global CAR-T Drugs Market Share by Players in 2024
Figure 24. Global CAR-T Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. The Top 10 and 5 Players Market Share by CAR-T Drugs Revenue in 2024
Figure 26. North America CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. North America CAR-T Drugs Market Share by Country (2020-2031)
Figure 28. United States CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Canada CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe CAR-T Drugs Market Share by Country (2020-2031)
Figure 32. Germany CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. France CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. U.K. CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Italy CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Russia CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Ireland CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific CAR-T Drugs Market Share by Region (2020-2031)
Figure 40. China CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Japan CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. South Korea CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Southeast Asia CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. India CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Australia & New Zealand CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America CAR-T Drugs Market Share by Country (2020-2031)
Figure 48. Mexico CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Brazil CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa CAR-T Drugs Market Share by Country (2020-2031)
Figure 52. Israel CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. UAE CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Gilead Sciences Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 57. Bristol Myers Squibb Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 58. Johnson & Johnson (Legend Biotech) Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 59. Fosun Kairos Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 60. ISAO Bio Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 61. JW (Cayman) Therapeutics Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 62. CARsgen Therapeutics Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 63. Juventas Cell Therapy Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 64. Hrain Biotechnology Co Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global CAR-T Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Single Target
Table 3. Key Players of Multiple Targets
Table 4. Global CAR-T Drugs Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Autologous
Table 6. Key Players of Allogeneic
Table 7. Global CAR-T Drugs Market Size Growth Rate by Generation (US$ Million): 2020 VS 2024 VS 2031
Table 8. Key Players of First Generation
Table 9. Key Players of Second Generation
Table 10. Key Players of Third Generation
Table 11. Key Players of Fourth Generation
Table 12. Global CAR-T Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 13. Global CAR-T Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global CAR-T Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 15. Global CAR-T Drugs Market Share by Region (2020-2025)
Table 16. Global CAR-T Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 17. Global CAR-T Drugs Market Share by Region (2026-2031)
Table 18. CAR-T Drugs Market Trends
Table 19. CAR-T Drugs Market Drivers
Table 20. CAR-T Drugs Market Challenges
Table 21. CAR-T Drugs Market Restraints
Table 22. Global CAR-T Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 23. Global CAR-T Drugs Market Share by Players (2020-2025)
Table 24. Global Top CAR-T Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Drugs as of 2024)
Table 25. Ranking of Global Top CAR-T Drugs Companies by Revenue (US$ Million) in 2024
Table 26. Global 5 Largest Players Market Share by CAR-T Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 27. Global Key Players of CAR-T Drugs, Headquarters and Area Served
Table 28. Global Key Players of CAR-T Drugs, Product and Application
Table 29. Global Key Players of CAR-T Drugs, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CAR-T Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 32. Global CAR-T Drugs Revenue Market Share by Type (2020-2025)
Table 33. Global CAR-T Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 34. Global CAR-T Drugs Revenue Market Share by Type (2026-2031)
Table 35. Global CAR-T Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 36. Global CAR-T Drugs Revenue Market Share by Application (2020-2025)
Table 37. Global CAR-T Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 38. Global CAR-T Drugs Revenue Market Share by Application (2026-2031)
Table 39. North America CAR-T Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. North America CAR-T Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 41. North America CAR-T Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 42. Europe CAR-T Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Europe CAR-T Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Europe CAR-T Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Asia-Pacific CAR-T Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 46. Asia-Pacific CAR-T Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 47. Asia-Pacific CAR-T Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 48. Latin America CAR-T Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Latin America CAR-T Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 50. Latin America CAR-T Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 51. Middle East & Africa CAR-T Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Middle East & Africa CAR-T Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 53. Middle East & Africa CAR-T Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 54. Gilead Sciences Company Details
Table 55. Gilead Sciences Business Overview
Table 56. Gilead Sciences CAR-T Drugs Product
Table 57. Gilead Sciences Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 58. Gilead Sciences Recent Development
Table 59. Novartis Company Details
Table 60. Novartis Business Overview
Table 61. Novartis CAR-T Drugs Product
Table 62. Novartis Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Bristol Myers Squibb Company Details
Table 65. Bristol Myers Squibb Business Overview
Table 66. Bristol Myers Squibb CAR-T Drugs Product
Table 67. Bristol Myers Squibb Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 68. Bristol Myers Squibb Recent Development
Table 69. Johnson & Johnson (Legend Biotech) Company Details
Table 70. Johnson & Johnson (Legend Biotech) Business Overview
Table 71. Johnson & Johnson (Legend Biotech) CAR-T Drugs Product
Table 72. Johnson & Johnson (Legend Biotech) Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 73. Johnson & Johnson (Legend Biotech) Recent Development
Table 74. Fosun Kairos Company Details
Table 75. Fosun Kairos Business Overview
Table 76. Fosun Kairos CAR-T Drugs Product
Table 77. Fosun Kairos Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 78. Fosun Kairos Recent Development
Table 79. ISAO Bio Company Details
Table 80. ISAO Bio Business Overview
Table 81. ISAO Bio CAR-T Drugs Product
Table 82. ISAO Bio Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 83. ISAO Bio Recent Development
Table 84. JW (Cayman) Therapeutics Company Details
Table 85. JW (Cayman) Therapeutics Business Overview
Table 86. JW (Cayman) Therapeutics CAR-T Drugs Product
Table 87. JW (Cayman) Therapeutics Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 88. JW (Cayman) Therapeutics Recent Development
Table 89. CARsgen Therapeutics Company Details
Table 90. CARsgen Therapeutics Business Overview
Table 91. CARsgen Therapeutics CAR-T Drugs Product
Table 92. CARsgen Therapeutics Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 93. CARsgen Therapeutics Recent Development
Table 94. Juventas Cell Therapy Company Details
Table 95. Juventas Cell Therapy Business Overview
Table 96. Juventas Cell Therapy CAR-T Drugs Product
Table 97. Juventas Cell Therapy Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 98. Juventas Cell Therapy Recent Development
Table 99. Hrain Biotechnology Co Company Details
Table 100. Hrain Biotechnology Co Business Overview
Table 101. Hrain Biotechnology Co CAR-T Drugs Product
Table 102. Hrain Biotechnology Co Revenue in CAR-T Drugs Business (2020-2025) & (US$ Million)
Table 103. Hrain Biotechnology Co Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. CAR-T Drugs Picture
Figure 2. Global CAR-T Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-T Drugs Market Share by Type: 2024 VS 2031
Figure 4. Single Target Features
Figure 5. Multiple Targets Features
Figure 6. Global CAR-T Drugs Market Size Comparison by Source (2020-2031) & (US$ Million)
Figure 7. Autologous Features
Figure 8. Allogeneic Features
Figure 9. Global CAR-T Drugs Market Size Comparison by Generation (2020-2031) & (US$ Million)
Figure 10. First Generation Features
Figure 11. Second Generation Features
Figure 12. Third Generation Features
Figure 13. Fourth Generation Features
Figure 14. Global CAR-T Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 15. Global CAR-T Drugs Market Share by Application: 2024 VS 2031
Figure 16. Hematoma Case Studies
Figure 17. Solid Tumors Case Studies
Figure 18. Others Case Studies
Figure 19. CAR-T Drugs Report Years Considered
Figure 20. Global CAR-T Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 21. Global CAR-T Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 22. Global CAR-T Drugs Market Share by Region: 2024 VS 2031
Figure 23. Global CAR-T Drugs Market Share by Players in 2024
Figure 24. Global CAR-T Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. The Top 10 and 5 Players Market Share by CAR-T Drugs Revenue in 2024
Figure 26. North America CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. North America CAR-T Drugs Market Share by Country (2020-2031)
Figure 28. United States CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Canada CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe CAR-T Drugs Market Share by Country (2020-2031)
Figure 32. Germany CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. France CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. U.K. CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Italy CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Russia CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Ireland CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific CAR-T Drugs Market Share by Region (2020-2031)
Figure 40. China CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Japan CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. South Korea CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Southeast Asia CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. India CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Australia & New Zealand CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America CAR-T Drugs Market Share by Country (2020-2031)
Figure 48. Mexico CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Brazil CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa CAR-T Drugs Market Share by Country (2020-2031)
Figure 52. Israel CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. UAE CAR-T Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Gilead Sciences Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 57. Bristol Myers Squibb Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 58. Johnson & Johnson (Legend Biotech) Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 59. Fosun Kairos Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 60. ISAO Bio Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 61. JW (Cayman) Therapeutics Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 62. CARsgen Therapeutics Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 63. Juventas Cell Therapy Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 64. Hrain Biotechnology Co Revenue Growth Rate in CAR-T Drugs Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232